0.5720
-0.0559
(-8.90%)
At close: 4:00:01 PM EDT
0.6196
+0.05
+(8.32%)
After hours: 5:32:16 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-191,540
-191,540
-111,616
3,549
-81,679
Investing Cash Flow
218,508
218,508
-3,924
-35,022
-97,315
Financing Cash Flow
94,054
94,054
137,554
48,313
3,256
End Cash Position
191,162
191,162
70,140
48,126
31,286
Income Tax Paid Supplemental Data
17,520
17,520
379
--
103
Interest Paid Supplemental Data
310
310
1,126
1,869
2,046
Capital Expenditure
-3,098
-3,098
-4,315
-7,858
-15,323
Issuance of Capital Stock
96,527
96,527
11,971
56,270
--
Repayment of Debt
-4,083
-4,083
-12,500
-9,375
--
Repurchase of Capital Stock
--
--
--
--
-7
Free Cash Flow
-194,638
-194,638
-115,931
-4,309
-97,002
12/31/2021 - 9/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTV Artiva Biotherapeutics, Inc.
1.8400
-7.54%
CTMX CytomX Therapeutics, Inc.
0.4946
-1.14%
MRSN Mersana Therapeutics, Inc.
0.2614
-13.90%
ALXO ALX Oncology Holdings Inc.
0.4800
-7.46%
MGNX MacroGenics, Inc.
1.2500
-1.57%
REPL Replimune Group, Inc.
6.92
-5.34%
SNDX Syndax Pharmaceuticals, Inc.
10.52
-8.68%
STTK Shattuck Labs, Inc.
0.9063
-1.93%
LXEO Lexeo Therapeutics, Inc.
2.1700
-8.05%
ABVC ABVC BioPharma, Inc.
1.0500
+7.14%